TA-65 featured in DISCOVER Science, Technology and The Future, May 2010
Can A Pill Keep You Young?
Wednesday, June 16th, 2010Long Island Closes In on The Fountain of Youth
Wednesday, June 16th, 2010Dr. Frederic Vagnini featured in The Boulevard magazine.
TA-65 on BBC
Wednesday, June 16th, 2010TA-65, telomerase activation and Bill Andrews featured on BBC program titled Don’t Grow Old
TA Sciences on CBS 2 News
Friday, November 13th, 2009Stacey Butler of CBS2 NewsCentral talks about telomerase activation with TA-65. (more…)
Anti-Aging Pill Targets Telomeres at the Ends of Chromosomes
Monday, August 17th, 2009From Scientific American
August 17, 2009
Could the secrets to anti-aging be at the tips of our chromosomes?
By Mandy Kendrick
Peter Pan stayed forever young in Neverland. In real life, some scientists are looking at telomeres, or regions of repetitive DNA at the ends of our chromosomes, to try to arrive at something like a real version of this story. (more…)
T.A. Sciences featured in Toronto Globe article on anti-aging.
Friday, January 9th, 2009T.A. Sciences founder Noel Patton featured in Toronto Globe article on anti-aging.
“The quest for the test tube of youth
First they beat the squares, the war and the patriarchy. Now the baby-boom generation wants to outwit Father Time. Fears of mortality and elder-care burdens are giving science a senior moment as labs investigate how to sustain healthy vigour far into old age. But is cheating frailty and death more than a vain dream?”
TA-65 mentioned in Newsweek
Sunday, December 7th, 2008T.A Sciences and our exclusive produt, TA-65 was mentioned in Newsweek.
“Telomere biologist Bill Andrews of Sierra Sciences is taking a telomerase-boosting supplement called TA-65. “I believe it’s safer than driving my car to work,” he says. Since he started taking it a year and a half ago, Andrews says he has moved from the back of the pack to the front in 100-mile runs known as ultramarathons.”
Trial results shows TA-65 leads to improved skin condition among older people
Tuesday, June 5th, 2007New York — Telomerase Activation Sciences Inc., based here, has announced the results of its Pivotal 2005 Anti-Aging Trial of TA-65, the first human trial to show measurable and positive anti-aging benefits — including improvement in skin condition — from a Telomerase activator, PRNewswire reports.
The Pivotal 2005 Anti-Aging Trial was a 24-week double-blind, placebo-controlled study involving 36 male subjects between 60 and 85 years of age. The study notes that there has been significant research on the role of cellular aging and telomere attrition in several types of skin cells, including keratinocytes, fibroblasts, microvascular endothelial cells and melanocytes. The results of this study suggest that TA-65 improves the structure and/or function of skin in older people.
According to PRNewswire, the study results also showed that subjects experienced improvement in immune system function, vision, sexual function, energy levels and overall sense of well-being.